The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer

Adv Exp Med Biol. 1995;362:139-43. doi: 10.1007/978-1-4615-1871-6_17.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Biomarkers / blood
  • Humans
  • Incidence
  • Japan / epidemiology
  • Mass Screening / methods*
  • Middle Aged
  • Pepsinogens / blood*
  • Stomach Ulcer / diagnosis*
  • Stomach Ulcer / epidemiology
  • Stomach Ulcer / prevention & control
  • Time Factors

Substances

  • Biomarkers
  • Pepsinogens